- Social Determinants of Health (SDOH): Leiva addressed the importance of understanding of the impact of SDOH on a person's life and medical journey, particularly within the context of oncology care. SDOH can intersect with various aspects of a person's identity, such as race, ethnicity, sexual orientation, gender identity, socioeconomic factors, and their influence on cancer outcomes.
- Equity Framework in Cancer Care: Leiva explained that SDOH within an equity framework in oncology looks at how disparities, marginalization, and stigmatization can lead to inequity in cancer care. Leiva emphasized the need for understanding and addressing these factors to improve outcomes for all patients.
- Collection and Importance of Sexual Orientation and Gender Identity (SOGI) Data: Leiva noted that recognizing sexual orientation and gender identity is an essential component of a person's identity and health. Specifically, it is important to collect and understand SOGI data when providing comprehensive care for patients, especially within the LGBTQ+ community.
- Role of Oncology Pharmacists: Leiva highlighted the unique role of oncology pharmacists in addressing SDOH, as they can reduce financial toxicities and improve outcomes. Leiva emphasized the pharmacist's ability to analyze data, intervene at various levels, and collaborate within multidisciplinary teams to enhance patient care.
- Challenges Without Pharmacist Involvement: Leiva explored the potential consequences of not having pharmacists integrated into the patient care team. Leiva discussed how the absence of pharmacists can lead to gaps in information, potentially impacting the direction of care, hindering patient participation, and creating barriers to clinical trial access, especially for marginalized communities.